Purpose
- Glioblastoma Multiforme (GBM) is locally aggressive
- GBM is the most common primary brain tumor in adults
- Surgery followed by temozolomide and radiotherapy are the standard of care
- Attempts have been made to increase radiation dose, pursue more aggressive chemotherapy, or add targeted therapy
- Biomarker expression may help individualize treatment decisions